Specifically, Hes1 was shown to negatively regulate PTEN, an inhibitor of PI3K/Akt signaling, in thymocytes and T-cell lymphoblastic leukemia (T-ALL) cells [39], [40]. This evidence concerns the gene HES1 and acute lymphoblastic leukemia.